The objectives of the present experiment were to examine the effects of in utero exposure to a b-adrenergic agonist ( L 644,969 ) on prenatal and postnatal muscle growth and meat tenderness of lambs. Thirty twin-pregnant Composite IV (1/2 Finnsheep, 1/8 Dorset, 1/8 Rambouillet, 1/8 Targhee, 1/8 Suffolk) ewe lambs were used for this experiment. All ewes were fed an alfalfa hay-corn-based diet throughout gestation and lactation. From d 25 to 95 of gestation, the diet of one-half of the ewes contained 2 ppm of L 644,969 on an as-fed basis. Treatment did not ( P > .05) affect lamb weights at any point in the growth cycle (birth to 43 kg). Heart weights of neonatal and market lambs were increased ( P < .05) by in utero exposure to L 644,969 . However, weights of lamb carcass components and weights of individual muscles were not affected by treatment ( P > .05). Additionally, treatment did not alter the activities of any of the components of the calpain proteolytic system in neonatal or market lambs. Concomitantly, there was no effect of treatment on myofibril fragmentation index or Warner-Bratzler shear force. Moreover, there was no effect of treatment on muscle fiber type distributions, fiber sizes, or apparent fiber number. It seems that the lack of an effect of treatment on apparent fiber number would explain the lack of an effect on muscle weight. Thus, in utero exposure to L 644,969 does not seem to have promise as a method for improving lamb carcass cutability. Other methods of improving the rate and composition of lamb carcass growth while maintaining acceptable meat tenderness must be developed.
Introduction
It is widely accepted that the meat industry must increase the efficiency of lean meat production. When fed during the latter stages of the finishing phase, badrenergic agonists ( BAA) have been shown to increase carcass cutability and decrease meat tenderness in lamb (Hamby et al., 1986; Lee et al., 1988; Wang et al., 1988; Beermann et al., 1989; Kretchmar et al., 1990; Pringle et al., 1993) . The increased muscle hypertrophy and decreased meat tenderness associated with BAA treatment has been attributed to increased calpastatin activity (Higgins et al., 1988; Kretchmar et al., 1989; Pringle et al., 1993) . Heretofore, efforts to achieve BAA-induced muscle growth without concomitant decreases in meat tenderness have been unsuccessful. Withdrawal of these compounds before slaughter does eliminate the BAA-induced toughening, but the cutability effect is also lost (Gwartney et al., 1991) . Maltin et al. (1990) demonstrated that in utero exposure to a BAA decreased postnatal muscle growth in rats. Kim et al. (1994) reported that treatment of sows with a BAA during either of the first two-thirds of pregnancy resulted in increased longissimus area in the carcasses of the progeny. The mechanisms by which prenatal BAA treatment alters muscle growth have not yet been fully explored. Moreover, it has not been established whether prenatal BAA treatment has an effect on meat tenderness. Additionally, the effects of in utero exposure to a BAA have not been determined in a ruminant species. Thus, the objectives of the present experiment were to determine the effects of in utero exposure to a b-adrenergic agonist One lamb, from each set of twins, was killed within 24 h of birth to assess the effects of in utero exposure to BAA on prenatal growth. The remaining lamb from each set of twins and all single lambs were reared conventionally. Lambs were tail-docked and males were castrated at birth. Lambs were weaned at 57 to 63 d of age. From weaning until slaughter, lambs were allowed ad libitum access to a standard growingfinishing diet (Table 1) . Lamb weights were determined weekly from birth to slaughter and feed consumption was determined weekly throughout the growing-finishing phase. Lambs were slaughtered at a mean weight of 43 kg BW. To facilitate collection of postmortem data, lambs were slaughtered in two groups with 3 wk between. The oldest half of each treatment group was included in the first slaughter group.
At slaughter, the head, pelt, heart, lungs, liver, spleen, kidneys, kidney-pelvic fat, and viscera (gastrointestinal tract) were weighed. The viscera were not emptied before weighing.
The longissimus muscle was removed from the left side of each carcass within 20 min after death for determination of the activities of the components of the calpain proteolytic system. Samples were assayed for activity of m-and m-calpain and calpastatin according to Koohmaraie (1990) .
Following chilling (24 h at 2°C), carcass sides were dissected and individual weights of all the major muscles, combined weight of the minor muscles, and weights of fat and bone were recorded. The muscles that were weighed individually were the adductor, biceps femoris, infraspinatus, longissimus, psoas group (psoas major and psoas minor combined), quadriceps femoris (rectus femoris, vastus medialis, vastus intermedius, and vastus lateralis combined), semimembranosus, semitendinosus, supraspinatus, gluteus group (gluteus medius, gluteus profundus, and gluteus accessorius combined). Muscle nomenclature was based on Tucker et al. (1952) .
Longissimus myofibril fragmentation index (Culler et al., 1978) and Warner-Bratzler shear force were determined after 1, 7, and 14 d postmortem for the market lambs. Due to the small size of the neonatal lamb carcasses, Warner-Bratzler shear force could not be determined and myofibril fragmentation index could only be determined twice ( 1 and 14 d postmortem).
Longissimus muscles were obtained at 24 h postmortem from the market lambs and several .7-cm 3 samples were frozen on cork in liquid nitrogen-cooled isopentane and stored at -70°C. Transverse cryostat sections, 10 mm thick, were cut and allowed to air dry. Sections were stained according to the procedures for simultaneous staining of bovine muscle fiber types described by Solomon and Dunn (1988) . A minimum of 200 fibers per animal were classified as bR, aR, or aW according to the classification of Ashmore and Doerr (1971) . Fiber areas were measured by Microcomp PM (Southern Micro Instruments, Atlanta, GA) interactive image analysis for planar morphometry. Apparent fiber number was determined (Swatland, 1984) on psoas major and semitendinosus at two locations ( 3 cm from the origin or insertion). At each sample location the area of the muscle was measured and two samples were obtained and frozen as described above. Fiber density was determined on four contiguous fields from each location. Fiber density and muscle area data were used to calculate apparent fiber number.
Statistical Analysis. For all dependent variables associated with the ewes, one-way ANOVA were conducted to assess the effect of treatment (SAS, 1988) . For all dependent variables associated with the lambs, sex was included in a factorially arranged randomized model (SAS, 1988) .
Results and Discussion

Effects of β-Adrenergic Agonist
Growth rate and feed efficiency of the ewes were not affected by L 644,969 (Table 2 ). In contrast, growth rate and feed efficiency of feedlot lambs have been reported to increase 10 to 15% with L 644,969 (Convey et al., 1987; Pringle et al., 1993) . badrenergic agonist treatment did not affect the percentage of ewes that had twin lambs, which is indicative of no effect of treatment on embryo or fetus survival. Moreover, lamb birth weights and total fetal weights (the sum of the birth weights of all the lambs born in a litter) were not altered by treatment.
In utero exposure to L 644,969 did not affect lamb weights at any point in the growth cycle (birth to 43 kg); consequently, slaughter weights did not differ between treatments (Table 3) . Of all the traits measured in this experiment, only heart weight was affected by in utero exposure to L 644,969 . Heart weights of neonatal and market lambs were increased (21 and 13%, respectively) by in utero exposure to L 644,969 . Maltin et al. (1990) reported that in utero exposure to clenbuterol resulted in increased fetal heart weights in rats. Moreover, placental transfer of clenbuterol has been observed in human pregnancy (Pelkonen et al., 1982) .
Whereas it has been reported that in utero exposure to a b-adrenergic agonist decreased hindlimb muscle weights in rats (Maltin et al., 1990 ) and increased longissimus area in pigs (Kim et al., 1994) , in utero exposure to L 644,969 did not affect weights of lamb carcass components or individual muscles in the present experiment (Table 4) .
Treatment did not alter the activities of any of the components of the calpain proteolytic system in neonatal or market lambs (Table 5 ). This was consistent with the lack of effect of treatment on myofibril fragmentation index or Warner-Bratzler shear force. Kim et al. (1994) reported that in utero exposure to salbutamol resulted in an increased proportion of type I fibers in the deep portion of the semitendinosus of pigs. In contrast, for longissimus and psoas major, the distribution of muscle fiber types was not affected in Table 3 . the present experiment (Table 6 ). Moreover, treatment did not affect fiber areas for longissimus and psoas major or apparent fiber number of psoas major and semitendinosus. Maltin et al. (1990) observed that total fiber number and muscle weight were reduced for rats exposed to clenbuterol during pregnancy. It would seem that the effect (or lack thereof) of in utero exposure to a b-adrenergic agonist is mediated through its effect (or lack thereof) on fiber number. It is not apparent why in utero exposure to L 644,969 did not affect fiber number in sheep. Numerous differences existed between our experiment and previous investigations of the effects of in utero exposure to a b-adrenergic agonist that might have contributed to the conflicting results among these studies. These differences included species, drug, dosage, and timing and duration of treatment. That heart weight of neonatal and market-weight lambs was altered by treatment serves as circumstantial evidence that L 644,969 crossed the placenta and affected lamb development. However, it cannot be ruled out that higher concentrations of L 644,969 would have resulted in alterations in lamb muscle development. Moreover, alteration of the timing of treatment might have resulted in alterations in lamb muscle development. However, that there was not even a tendency for treatment to increase muscle growth rates suggests that alterations in the protocol would not result in a significant effect in lambs. 
Effects of Sex
Sex did not affect slaughter weights of neonatal or market lambs; however, at market weight, wethers had higher head and hot carcass weights than ewes (Table 7) . Among neonatal and market lambs, males had higher heart weights than did females (Table 7) .
At market weight, wethers had higher weights of lean and bone than ewes (Table 8) ; however, the relative proportion of each carcass component was not affected by sex (data not presented in tabular form). Whereas ewes have been reported to be fatter than wethers (Oliver et al., 1967) , ewes tended to have a lower percentage of the carcass composed of fat than wethers in the present experiment. Dissected muscle weight differences between sexes paralleled the hot carcass weight differences between sexes. Among neonatal lambs, hot carcass weights were numerically higher for rams than for ewes ( P = .12). Concomitantly, all muscle weights were numerically higher for rams, the gluteus group, psoas group, and semitendinosus were significantly heavier. Among market lambs, hot carcass weights and weights of 8 of the 10 muscles were higher ( P < .05) for rams than for ewes.
Sex did not affect ( P > .05) any of the components of the calpain system, myofibril fragmentation index, or Warner-Bratzler shear force (Table 9 ). However, Warner-Bratzler shear force at d 14 postmortem tended ( P = .06) to be lower for wethers than for ewes, possibly due to a trend ( P = .11) toward reduced calpastatin activity for wethers compared to ewes. Oliver et al. (1967) and Summers et al. (1978) reported that longissimus shear force did not differ between ewes and wethers.
Sex did not affect muscle fiber areas for longissimus or psoas major (Table 10) . Moreover, the distribution of fiber types was similar among sexes. However, apparent fiber number of semitendinosus was significantly higher ( P < .05) for wethers than for ewes and apparent fiber number of psoas major was numerically higher ( P = .12) for wethers. For the psoas major, fiber number ( r = .57; P = .001) was more highly related to muscle weight than was fiber area ( r = .15; P = .46). Because muscle mass differed to a greater extent between males and females than did fiber diameter, Joubert (1956) speculated that muscle fiber number was greater for males than females.
In conclusion, in utero exposure of lambs to L 644,969 , a b-adrenergic agonist that has been shown to markedly improve carcass composition in market lambs via muscle hypertrophy, did not affect prenatal or postnatal muscle growth. Although altering the timing, duration, and level of L 644,969 treatment might result in an effect on muscle growth, results of this study did not give any indication that in utero exposure to a b-adrenergic agonist has any promise as a method for improving the composition of lamb carcasses. Increased fiber number rather than increased fiber size may be responsible for increased muscle mass of males compared to that of females.
Implications
In utero exposure of lambs to a b-adrenergic agonist did not affect growth. Thus, other methods of improving the rate and composition of lamb carcass growth while maintaining acceptable meat tenderness must be developed.
